Syndax Pharmaceuticals, Inc. (SNDX) vs Vor Biopharma Inc. (VOR)

Syndax Pharmaceuticals, Inc. and Vor Biopharma Inc. are both Biotechnology companies. Syndax Pharmaceuticals, Inc. and Vor Biopharma Inc. are of similar size ($1.2B and $1.1B). Vor Biopharma Inc. has the higher net margin (0.00% vs −87.6%) and the higher return on invested capital (0.00% vs −247.9%). Across the 13 metrics below, Vor Biopharma Inc. leads on 9 and Syndax Pharmaceuticals, Inc. on 4.

Valuation

Metric SNDX VOR Biotechnology median
P/E n/m n/m 8.50
P/S 4.55 n/m 9.71
P/B 75.91 6.97 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 4.77 n/m 9.21
Earnings yield (19.49%) (2,102.61%) (33.15%)
Free cash flow yield (19.27%) (7.76%) (25.50%)

Profitability

Metric SNDX VOR Biotechnology median
Gross margin 95.78% 0.00% 65.16%
Operating margin (77.05%) — 0.00%
Net margin (87.60%) 0.00% 0.00%
Free cash flow margin (87.64%) 0.00% 0.00%
Return on equity (255.93%) (69.27%) (56.36%)
Return on assets (33.97%) 0.00% (48.04%)
Return on invested capital (247.93%) 0.00% 0.00%

Growth

Metric SNDX VOR Biotechnology median
Revenue growth (TTM) 222.34% — 6.02%
EPS growth (last fiscal year) 11.56% (107.35%) 30.26%
Revenue growth, 5-year CAGR 157.68% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SNDX VOR Biotechnology median
Debt to equity 38.95 0.21 0.00
Current ratio 6.77 10.69 4.72
Net debt to EBITDA 0.25 2.27 0.96

Dividend

Metric SNDX VOR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric SNDX VOR Biotechnology median
Market cap 1.22b 1.14b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack